Kickoff Call · Week 0 · Day 0

Let's build something
great together.

Today we'll align on goals, walk through what we've already researched about your business, and get access to everything we need to start your audit.

60
Minutes
7
Sections
3
Goals
Month 1 Timeline
Day 0 · Today
Kickoff call, access + goals
NOW
Weeks 1–2
Two-brand audit: Miami Stem Cell + BetterStem
End of Week 2
Audit review session — go/no-go decision
Weeks 3–4
30/60/90 day plan delivery
Section 1 · 5 min
Today's Agenda
8 topics · 60 minutes · one clear outcome: a running start
01
Team Intros
Who's on the MH1 team and what each of us owns
5 MIN
02
Today's Goals
Align objectives, set expectations, request access
5 MIN
03
Brand Snapshot
What we researched on both brands before this call
5 MIN
04
Business Fundamentals
Budget, lead funnel, conversion, two-brand split
15 MIN
05
Customer Deep Dive
Two distinct ICPs: pain-management adults + autism families
10 MIN
06
Tech Stack & Access
Zenoti, LeadConnector, GA4, ad accounts, GMB
10 MIN
07
What Happens Next
Audit scan → review → 30/60/90 plan
10 MIN
Q & A
Open questions, anything we missed
Buffer
Section 2 · 5 min
Today's Goals
Three outcomes we're walking away with today
01
Align Objectives
We leave with shared clarity on what success looks like across both brands — CPL targets, lead-to-consult-to-treatment conversion, treatment volume goals — and what we're each accountable for over the next 4 weeks.
02
Share What to Expect
You understand how MH1 works at the growth-marketer + AI tooling tier — our process, communication cadence, deliverables, and what the audit + 30/60/90 plan looks like.
03
Request What We Need
We collect platform access, data, lead pipeline context, and the two-brand split (Miami Stem Cell + BetterStem) so we can run the MH-1 audit without follow-up delays.
Section 3 · 5 min
Brand Snapshot — What We Know
Research we completed before this meeting — validate, correct, and add context
Miami Stem Cell
Researched before this meeting
Industry Regenerative medicine — Miami Stem Cell (adult: pain, longevity, ortho) + BetterStem (autism — sub-brand)
Model Patient-pay clinic services. Funnel: inquiry → free consult → diagnostic workup → treatment plan. $4K–$15K+ per procedure. Financing offered. Two brands, billed under Miami Stem Cell.
Primary Channel Google (search + SEO via existing agency). Social paid recently terminated. Strong content/blog SEO foundation.
Key Metric Lead → Consult → Treatment conversion (both brands). CPL by ICP segment.
Sales Process Form / phone inquiry → free consultation (Zenoti / Calendly) → diagnostic (FRAT, gut panel for BetterStem) → personalized treatment plan
Geographic Focus South Miami, FL + Honolulu, HI today. National expansion target: 2 years. International: year 3.
Marketing Maturity Mid — strong content/SEO foundation (8,500+ procedures, structured FAQ + comparison content, EY Entrepreneur of the Year founder). Weak paid social attribution (agency just terminated). Founder + doctors not currently on-camera; autism content production planned. Heavy regulatory copy constraints (stem cells classified as investigational on Google/Meta).
Section 4 · 3 min
Your MH1 Team
The people working your account — and what each of us owns
R
Raaja
Founder & Chief Growth Officer
C
Chris
Founder & CEO
J
Jarred
Operations Lead
J
Josh
MH1 Technical Lead
Growth
Growth Marketer (assigned)
👥
Co-Pilots — Scaled in After Audit Channel specialists added as we scale beyond the $10K growth-marketer tier
Section 5 · 15 min
Business Fundamentals
Intake questions — we go through these together
Channel Ownership — Who Owns Each Today?
Paid Search
Paid Social
Email / SMS
SEO
AEO
Content / Creative
CRO
Financials & Operations
→Confirm 2026 revenue goals across both brands (Miami Stem Cell + BetterStem)
→Approximate gross margin per treatment ($4K–$7K Miami Stem Cell, $10K–$15K+ BetterStem)?
→Current monthly marketing spend by channel — Google (existing agency), other?
→Target CPL and target Cost-Per-Treatment by brand?
→What is your conversion rate from Inquiry → Consult → Booked Treatment today?
→Top 3–5 competitors to benchmark — specifically for the autism / Right-to-Try lane?
Channels & Operations — B2B Lead Gen Focus
→Walk us through the backend: how does a form fill or phone call become a booked consult?
→Who handles inbound consult inquiries today — internal team, MAA consultant, or shared?
→How is Zenoti integrated with LeadConnector — single source of truth or split?
→Two-brand split: separate ad accounts, GA4 properties, CRM pipelines, or shared?
Marketing Channels & Audit Scope
→What's working in your existing Google agency engagement (search + SEO)?
→What didn't work with the Meta agency — channel limitations, regulatory flags, or scaling/team issues?
→Walk us through the regulatory copy constraints — what language has gotten flagged on Google or Meta?
→BetterStem launch priority: is the autism brand the headline, with Miami Stem Cell as the steady earner, or balanced?
→AEO opportunity — you're the only FDA-IND-active stem cell autism provider in the US. What's the plan to own ChatGPT / Perplexity recommendations?
→Founder content: you mentioned autism is your passion and you'd be willing to do content there — what cadence is realistic?
→What does success look like in 90 days? In 12 months?
→Where does the existing Google agency end and where do we begin — clean handoff or co-managed?
Section 6 · 10 min
Customer Deep Dive
Understanding who calls Miami Stem Cell, why they call, and what closes the job
Who They Are
→Two ICPs to validate: adult patients (Miami Stem Cell — pain, longevity, ortho) vs. parents of autism children (BetterStem). Note: parents are often adult patients too.
→Demographics — age, geography, income, payer status (cash-pay)?
→Decision-maker profile — for autism, which parent leads the decision? For Miami Stem Cell, self vs. spouse vs. referring physician?
Why & When They Buy
→Why do patients choose you over a competitor (FDA-IND-active, 8,500+ procedures, Florida-legal)?
→Trigger events — chronic pain not resolving, autism diagnosis, exhausted other options, post-injury, longevity-focused?
→What drives a referral or repeat visit? Is the autism family network a flywheel?
Feedback & Insights
→Reviews — what themes show up on Google / health-vertical platforms?
→Top objections handled in consults — price, regulatory, travel, efficacy concerns?
→Specific to BetterStem: what objections do parents raise that Miami Stem Cell parents don't?
Section 7 · 10 min
Technology Stack & Platform Access
We need admin access to each platform before the audit begins
Zenoti
Scheduling / booking — primary admin contact?
LeadConnector (CRM)
Lead routing + automation — admin contact + integration map
Google Analytics / GA4
Property ID(s) — one shared, or separate per brand?
Meta Ads
Ad account access — confirm post-agency-termination handoff
Google Ads
Account ID + access — coordinate with existing Google agency
Email / SMS
Platform + list size by brand
Google Search Console
Both domains: stemcellmia.com + betterstem.com
Google My Business
Profile admin — both Miami + Honolulu locations
Call Tracking
Currently in use? CallRail or LeadConnector native?
Section 8 · 10 min
What Happens After Today
The first four weeks — audit, review, and your 30/60/90 plan
01 Weeks 1–2
MH-1 Audit Scan
→Full data access request within 24 hrs (both brands)
→Audit: Google Ads, SEO, Meta, Zenoti, LeadConnector, GMB, GSC
→Lead pipeline analysis: inquiry → consult → treatment funnel by brand
→Competitive + AEO landscape: who's bidding on regen-med keywords + who LLMs cite for autism stem cell
02 End of Week 2
Audit Review Together
→Present MH-1 findings on both brands
→Walk through gaps + highest-leverage opportunities
→Two-brand prioritization: BetterStem launch vs. Miami Stem Cell baseline
→Vision alignment + go/no-go decision before plan is set
03 Weeks 2–4
30/60/90 Day Plan
→30-day: Tracking setup, regulatory copy framework, quick wins on existing Google
→60-day: Channel activation — AEO content, founder-led autism content, Meta relaunch
→90-day: Conversion optimization, lifecycle nurture, two-brand attribution
→KPI targets: CPL, Lead→Consult→Treatment, treatment volume by brand
→Sprint cadence + weekly check-ins confirmed
0%
Churn Since Launch
100%
Trial-to-Hire Rate
Month-to-Month
Cancel Anytime